Skip to content

2026 ACHONDROPLASIA & SKELETAL DYSPLASIA RESEARCH CONFERENCE • ORLANDO, FL

FRIDAY, MAY 22- SUNDAY, MAY 24
The Chandler Project
  • ABOUTExpand
    • MISSION
    • FOUNDER’S STORY
  • COMMUNITYExpand
    • Friends of Chandler
    • RARE-X
    • PICNIC HEALTH
    • THE MIGHTY
  • CONDITIONSExpand
    • ACHONDROPLASIA
    • HYPOCHONDROPLASIA
    • PSEUDOACHON.
    • SEDC
  • PHARMACHONExpand
    • Nurse Vic’s Notes
  • RESEARCHExpand
    • NEWS
    • STUDIES & TRIALS
    • Treatments & PipelinesExpand
      • BioMarin Pharmaceutical
      • QED Therapeutics
      • Ascendis Pharma
      • Tyra Biosciences
      • SANOFI
      • INNOSKEL
      • PFIZER (NULL)
  • CONTACT
Instagram Facebook Facebook Group Linkedin Email
The Chandler Project
Achondroplasia

touchEXPERT OPINIONS Clinical management strategies in achondroplasia: Current landscape and new horizons

via touchEndocrinology. Watch three leading experts explore how the pathophysiology of achondroplasia is being targeted by new and emerging pharmacotherapies to restore endochondral ossification. A roadmap to optimized current and future clinical management is also outlined.

Clinical management strategies in achondroplasia: Current landscape and new horizons

Clinical management strategies in achondroplasia: Current landscape and new horizons

Clinical management strategies in achondroplasia: Current landscape and new horizons

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on Threads (Opens in new window) Threads
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on Reddit (Opens in new window) Reddit
  • Share on WhatsApp (Opens in new window) WhatsApp
Post Tags: #CLINICAL MANAGEMENT#ENDOCRINOLOGY#PHARMACOTHERAPIES

Post navigation

Previous Previous
Lower limb biomechanics during gait in children with Achondroplasia
NextContinue
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia

Copyright © 2026 · The Chandler Project · Hello You Designs

translate ?
Scroll to top
  • ABOUT
    • MISSION
    • FOUNDER’S STORY
  • COMMUNITY
    • Friends of Chandler
    • RARE-X
    • PICNIC HEALTH
    • THE MIGHTY
  • CONDITIONS
    • ACHONDROPLASIA
    • HYPOCHONDROPLASIA
    • PSEUDOACHON.
    • SEDC
  • PHARMACHON
    • Nurse Vic’s Notes
  • RESEARCH
    • NEWS
    • STUDIES & TRIALS
    • Treatments & Pipelines
      • BioMarin Pharmaceutical
      • QED Therapeutics
      • Ascendis Pharma
      • Tyra Biosciences
      • SANOFI
      • INNOSKEL
      • PFIZER (NULL)
  • CONTACT
Search